We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Mayo and LipoScience in Collaboration

By Labmedica staff writers
Posted on 24 Aug 2005
A collaborative agreement between Mayo Clinic's Department of Laboratory Medicine and Pathology (Rochester, MN, USA) and LipoSciences (Raleigh, NC, USA) has been announced, whereby the Mayo Clinic will validate the clinical utility of the nuclear magnetic resonance (NMR) LipoProfile test of LipoSciences as a tool to measure cardiovascular risks.

As part of its assessment, Mayo researchers will determine the value of the NMR LipoProfile test independently and as part of its novel cardiovascular risk marker panel, a group of emerging risk factors used to aid doctors in the assessments of their patients' risks for developing cardiovascular disease or experiencing a cardiovascular event such as a stroke.

The NMR LipoProfile is a simple blood test used by doctors to directly measure the number of atherogenic low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) particles as well as protective high-density lipoprotein (HDL) particles. More...
Measuring the numbers of "bad” lipoprotein particles (LDL-P) has been found to provide a better indication of the risk of coronary heart disease than measuring the level of "bad” cholesterol.

"Mayo Clinic is widely recognized as a leader in assessing novel technologies that have the potential to significantly impact medical decisions and patient management,” explained Richard O. Brajer, president and chief executive officer at LipoScience, Inc. "We believe a preeminent institution such as Mayo Clinic will generate additional independent clinical data further confirming the clinical value of the NMR LipoProfile test.”




Related Links:
Mayo Medical Laboratories
LipoScience

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The automated multiplex PCR assay runs on the BioFire Spotfire Vaginitis System, bringing molecular vaginitis testing to the point of care (Photo courtesy of bioMérieux)

Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: The CE-marked software IVD combines digital histopathology and clinicopathological data to generate a prognostic classification (Image Credit: Shutterstock)

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.